Tagged with Pharma,

India Satish Kumar Singh (managing director) & Shashi Shekhar Kumar (vice president International Business) from M/s Cachet Pharmaceuticals Pvt. Ltd., discuss their success with special reference to marketing, distribution and operating strategies for non-regulated markets. M/s Cachet Pharmaceuticals Pvt. Ltd. is a subsidiary of M/s Alkem Laboratories Ltd. Mr. Singh, before…

Canada Madhu Venkat, CEO of Natco Pharma Canada, highlights the company’s portfolio strategy, its strategic road map to be the first mover and become a leading generic supplier in oncology by 2020. He further illustrates that to be successful in Canada, it pays off to be a niche player and vertically…

Switzerland Darren Kerr, CEO of Swiss medtech Stratpharma discusses, the company’s roots, its broad portfolio in dermatology, plastic surgery and scar management, as well as its growing international footprint.   We target very different market groups, from government and university teaching hospitals with cutting edge science, to the OTC field and…

Serbia CEO of Health Watch Swiss and general manager at Protonmed Serbia, Themis Moustakas has built a quality company thanks to Swiss practices and an entrepreneurial spirit over the last four years. Moustakas reveals how to best approach the mercurial Serbian market, the trick to bidding on government tenders, and how…

Switzerland Benjamin Rousselot of Swiss ear hygiene specialists Laboratoires Diepharmex discusses the history of the company, new products, and the pros and cons of ‘Swissness’. Laboratoires Diepharmex is a Swiss-based, family pharma outfit, established two decades ago and today very well known internationally for its ear hygiene product line, Audispray. Can…

Switzerland Benjamin Rousselot of Swiss ear hygiene specialists Laboratoires Diepharmex discusses the history of the company, new products, and the pros and cons of ‘Swissness’. Laboratoires Diepharmex is a Swiss-based, family pharma outfit, established two decades ago and today very well known internationally for its ear hygiene product line, Audispray. Can…

Brazil Alex Carvalho, general manager Pierre Fabre Brazil, provides insights into the rapidly ascending trajectory of the company in Brazil, its utmost commitment to oncology in the country, and Pierre Fabre’s eagerness to further investing in this strategic market. He also calls for a greater collaboration between all stakeholders to tackle…

Lithuania Mantas Katinas, general manager at Invest Lithuania, discusses the country’s strengths, how it can become an attractive destination for Foreign Direct Investment (FDI) and the commitment of the agency towards developing a proper ecosystem for life sciences in Lithuania. Mr. Katinas, you worked in the telecoms industry before joining Invest…

Switzerland Jeff Dufour, country manager Switzerland and BU lead Internal Medicine at Pfizer, discusses his first impressions of the country, his priorities for greater dialogue with Swiss healthcare insurers, and Switzerland’s potential as a ‘test market’ for the company. Can you give our international readers an outline of your background and…

Serbia Milica Glisic, with over 15 years of experience in the pharma business and ten years at Wörwag Pharma, discusses the strong workforce in the Balkans, Wörwag Pharma’s mission in the West Balkan region, and the company’s dedication to providing unique and efficient solutions for diabetes and concomitant complications. Could you…

Canada Dr. Jean-Yves Leroux, CEO and founder of Medelys, lets his entrepreneurial fiber shine through in this interview as he talks about the beginnings of his company in 2006, the initial challenges, and the prospects for collagen-based natural health products in the treatment of joint pain resulting from arthritis and osteoporosis…

Canada Mark Nawacki, CEO and co-founder of Searchlight Pharma, affirms the company’s dedication to women’s health through a modern approach to current market trends. He underlines the company’s commitment to productive collaborations with healthcare professionals and industry partners and its aspiration to bring life-changing innovations to Canadian patients. Mark, can you…